title: Is antithrombotic prophylaxis required in cancer patients with central venous catheters? Still an open question.
authors.affiliation: Department of CE&B, McMaster University, Hamilton, ON, Canada. mlevine@mcmaster.ca
authors.forename: M
authors.initials: M
authors.lastname: Levine
mesh_terms: D002405:Catheterization, Central Venous / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D005343:Fibrinolytic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000150:complications*; D017410:Practice Guidelines as Topic; D011292:Premedication / Q000009:adverse effects*; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control*; D016896:Treatment Outcome
chemical_list: D005343:Fibrinolytic Agents